Detalhe da pesquisa
1.
Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.
PLoS Med;
18(8): e1003734, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34464388
2.
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics.
medRxiv;
2024 Mar 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38293154
3.
Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.
Neurooncol Adv;
2(Suppl 1): i75-i84, 2020 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32642734
4.
Preferentially Expressed Antigen in Melanoma (PRAME) Expression in Malignant, but Not Benign, Peripheral Nerve Sheath Tumors.
J Neuropathol Exp Neurol;
80(4): 384-386, 2021 03 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33212492